论文信息 - In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor. - 字舞流文

In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor.

J. Barata | M. G. Silva | D. Drygin | A. Melão | L. R. Martins | R. Stansfield | B. Cardoso | P. Lúcio